Interaction of a G Protein with an Activated Receptor Opens the Interdomain Interface in the Alpha Subunit
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
G Protein Alpha 13 (GNA13) (NM 006572) Human Tagged ORF Clone Lentiviral Particle Product Data
OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC207762L3V G protein alpha 13 (GNA13) (NM_006572) Human Tagged ORF Clone Lentiviral Particle Product data: Product Type: Lentiviral Particles Product Name: G protein alpha 13 (GNA13) (NM_006572) Human Tagged ORF Clone Lentiviral Particle Symbol: GNA13 Synonyms: G13 Vector: pLenti-C-Myc-DDK-P2A-Puro (PS100092) ACCN: NM_006572 ORF Size: 1131 bp ORF Nucleotide The ORF insert of this clone is exactly the same as(RC207762). Sequence: OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_006572.3 RefSeq Size: 4744 bp RefSeq ORF: 1134 bp Locus ID: 10672 UniProt ID: Q14344, A0A024R8M0 Domains: G-alpha Protein Families: Druggable Genome Protein Pathways: Long-term depression, Regulation of actin cytoskeleton, Vascular smooth muscle contraction MW: 44 kDa This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 G protein alpha 13 (GNA13) (NM_006572) Human Tagged ORF Clone Lentiviral Particle – RC207762L3V Gene Summary: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems (PubMed:15240885, PubMed:16787920, PubMed:16705036, PubMed:27084452). -
Identification of Residues of the H-Ras Protein Critical for Functional Interaction with Guanine Nucleotide Exchange Factors RAYMOND D
MOLECULAR AND CELLULAR BIOLOGY, Feb. 1994, p. 1104-1112 Vol. 14, No. 2 0270-7306/94/$04.00+0 Copyright © 1994, American Society for Microbiology Identification of Residues of the H-Ras Protein Critical for Functional Interaction with Guanine Nucleotide Exchange Factors RAYMOND D. MOSTELLER, JAEWON HAN, AND DANIEL BROEK* Department ofBiochemistry and Molecular Biology, Kenneth Norris Jr. Cancer Hospital and Research Center, University of Southern California School ofMedicine, Los Angeles, California 90033 Received 10 September 1993/Returned for modification 21 October 1993/Accepted 29 October 1993 Ras proteins are activated in vivo by guanine nucleotide exchange factors encoded by genes homologous to the CDC25 gene ofSaccharomyces cerevisiae. We have taken a combined genetic and biochemical approach to probe the sites on Ras proteins important for interaction with such exchange factors and to further probe the mechanism ofCDC25-catalyzed GDP-GTP exchange. Random mutagenesis coupled with genetic selection in S. cerevisiae was used to generate second-site mutations within human H-ras-alalS which could suppress the ability of the Ala-15 substitution to block CDC25 function. We transferred these second-site suppressor mutations to normal H-ras and oncogenic H-rasva1l2 to test whether they induced a general loss of function or whether they selectively affected CDC25 interaction. Four highly selective mutations were discovered, and they affected the surface-located amino acid residues 62, 63, 67, and 69. Two lines of evidence suggested that these residues may be involved in binding to CDC25: (i) using the yeast two-hybrid system, we demonstrated that these mutants cannot bind CDC25 under conditions where the wild-type H-Ras protein can; (ii) we demonstrated that the binding to H-Ras of monoclonal antibody Y13-259, whose epitope has been mapped to residues 63, 65, 66, 67, 70, and 73, is blocked by the mouse sosl and yeast CDC25 gene products. -
LPS Induces GFAT2 Expression to Promote O-Glcnacylation
1 LPS induces GFAT2 expression to promote O-GlcNAcylation and 2 attenuate inflammation in macrophages 3 4 5 Running title: GFAT2 is a FoxO1-dependent LPS-inducible gene 6 7 Hasanain AL-MUKH, Léa BAUDOIN, Abdelouhab BOUABOUD, José-Luis SANCHEZ- 8 SALGADO, Nabih MARAQA, Mostafa KHAIR, Patrick PAGESY, Georges BISMUTH, 9 Florence NIEDERGANG and Tarik ISSAD 10 11 Université de Paris, Institut Cochin, CNRS, INSERM, F-75014 Paris, France 12 Address correspondence to: Tarik Issad, Institut Cochin, Department of Endocrinology, 13 Metabolism and Diabetes, 24 rue du Faubourg Saint-Jacques, 75014 Paris FRANCE. Tel : + 33 1 14 44 41 25 67; E-mail: [email protected] 15 16 1 1 Abstract 2 O-GlcNAc glycosylation is a reversible post-translational modification that regulates the 3 activity of intracellular proteins according to glucose availability and its metabolism through 4 the hexosamine biosynthesis pathway (HBP). This modification has been involved in the 5 regulation of various immune cell types, including macrophages. However, little is known 6 concerning the mechanisms that regulate protein O-GlcNAcylation level in these cells. In the 7 present work, we demonstrate that LPS treatment induces a marked increase in protein O- 8 GlcNAcylation in RAW264.7 cells, bone-marrow-derived and peritoneal mouse 9 macrophages, as well as human monocyte-derived macrophages. Targeted deletion of OGT in 10 macrophages resulted in an increased effect of LPS on NOS2 expression and cytokine 11 production, suggesting that O-GlcNAcylation may restrain inflammatory processes induced 12 by LPS. The effect of LPS on protein O-GlcNAcylation in macrophages was associated with 13 an increased expression and activity of glutamine fructose 6-phosphate amido-transferase 14 (GFAT), the enzyme that catalyzes the rate-limiting step of the HBP. -
A Role for N-Myristoylation in Protein Targeting
A Role for N-Myristoylation in Protein Targeting: NADH-Cytochrome b5 Reductase Requires Myristic Acid for Association with Outer Mitochondrial But Not ER Membranes Nica Borgese,** Diego Aggujaro,* Paola Carrera, ~ Grazia Pietrini,* and Monique Bassetti* *Consiglio Nazionale deUe Ricerche Cellular and Molecular Pharmacology Center, Department of Pharmacology, University of Milan, 20129 Milan, Italy; ~Faculty of Pharmacy, University of Reggio Calabria, 88021 Roccelletta di Borgia, Catanzaro, Italy; and ~Scientific Institute "San Raffaele," 20132 Milan, Italy Abstract. N-myristoylation is a cotranslational modifi- investigated by immunofluorescence, immuno-EM, and Downloaded from http://rupress.org/jcb/article-pdf/135/6/1501/1267948/1501.pdf by guest on 27 September 2021 cation involved in protein-protein interactions as well cell fractionation. By all three techniques, the wt pro- as in anchoring polypeptides to phospholipid bilayers; tein localized to ER and mitochondria, while the non- however, its role in targeting proteins to specific subcel- myristoylated mutant was found only on ER mem- lular compartments has not been clearly defined. The branes. Pulse-chase experiments indicated that this mammalian myristoylated flavoenzyme NADH-cyto- altered steady state distribution was due to the mu- chrome b 5 reductase is integrated into ER and mito- tant's inability to target to mitochondria, and not to its chondrial outer membranes via an anchor containing a enhanced instability in that location. Both wt and mu- stretch of 14 uncharged amino acids downstream to the tant reductase were resistant to Na2CO 3 extraction and NH2-terminal myristoylated glycine. Since previous partitioned into the detergent phase after treatment of studies suggested that the anchoring function could be a membrane fraction with Triton X-114, demonstrating adequately carried out by the 14 uncharged residues, that myristic acid is not required for tight anchoring of we investigated a possible role for myristic acid in re- reductase to membranes. -
RNF11 at the Crossroads of Protein Ubiquitination
biomolecules Review RNF11 at the Crossroads of Protein Ubiquitination Anna Mattioni, Luisa Castagnoli and Elena Santonico * Department of Biology, University of Rome Tor Vergata, Via della ricerca scientifica, 00133 Rome, Italy; [email protected] (A.M.); [email protected] (L.C.) * Correspondence: [email protected] Received: 29 September 2020; Accepted: 8 November 2020; Published: 11 November 2020 Abstract: RNF11 (Ring Finger Protein 11) is a 154 amino-acid long protein that contains a RING-H2 domain, whose sequence has remained substantially unchanged throughout vertebrate evolution. RNF11 has drawn attention as a modulator of protein degradation by HECT E3 ligases. Indeed, the large number of substrates that are regulated by HECT ligases, such as ITCH, SMURF1/2, WWP1/2, and NEDD4, and their role in turning off the signaling by ubiquitin-mediated degradation, candidates RNF11 as the master regulator of a plethora of signaling pathways. Starting from the analysis of the primary sequence motifs and from the list of RNF11 protein partners, we summarize the evidence implicating RNF11 as an important player in modulating ubiquitin-regulated processes that are involved in transforming growth factor beta (TGF-β), nuclear factor-κB (NF-κB), and Epidermal Growth Factor (EGF) signaling pathways. This connection appears to be particularly significant, since RNF11 is overexpressed in several tumors, even though its role as tumor growth inhibitor or promoter is still controversial. The review highlights the different facets and peculiarities of this unconventional small RING-E3 ligase and its implication in tumorigenesis, invasion, neuroinflammation, and cancer metastasis. Keywords: Ring Finger Protein 11; HECT ligases; ubiquitination 1. -
G-Protein ␥-Complex Is Crucial for Efficient Signal Amplification in Vision
The Journal of Neuroscience, June 1, 2011 • 31(22):8067–8077 • 8067 Cellular/Molecular G-Protein ␥-Complex Is Crucial for Efficient Signal Amplification in Vision Alexander V. Kolesnikov,1 Loryn Rikimaru,2 Anne K. Hennig,1 Peter D. Lukasiewicz,1 Steven J. Fliesler,4,5,6,7 Victor I. Govardovskii,8 Vladimir J. Kefalov,1 and Oleg G. Kisselev2,3 1Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63110, Departments of 2Ophthalmology and 3Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, Missouri 63104, 4Research Service, Veterans Administration Western New York Healthcare System, and Departments of 5Ophthalmology (Ross Eye Institute) and 6Biochemistry, University at Buffalo/The State University of New York (SUNY), and 7SUNY Eye Institute, Buffalo, New York 14215, and 8Sechenov Institute for Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, Saint Petersburg 194223, Russia A fundamental question of cell signaling biology is how faint external signals produce robust physiological responses. One universal mechanism relies on signal amplification via intracellular cascades mediated by heterotrimeric G-proteins. This high amplification system allows retinal rod photoreceptors to detect single photons of light. Although much is now known about the role of the ␣-subunit of the rod-specific G-protein transducin in phototransduction, the physiological function of the auxiliary ␥-complex in this process remains a mystery. Here, we show that elimination of the transducin ␥-subunit drastically reduces signal amplification in intact mouse rods. The consequence is a striking decline in rod visual sensitivity and severe impairment of nocturnal vision. Our findings demonstrate that transducin ␥-complex controls signal amplification of the rod phototransduction cascade and is critical for the ability of rod photoreceptors to function in low light conditions. -
Transducin -Subunit Can Interact with Multiple G-Protein ␥-Subunits to Enable Light Detection by Rod Photoreceptors
New Research Sensory and Motor Systems Transducin -Subunit Can Interact with Multiple G-Protein ␥-Subunits to Enable Light Detection by Rod Photoreceptors Paige M. Dexter,1 Ekaterina S. Lobanova,2 Stella Finkelstein,2 William J. Spencer,1 Nikolai P. Skiba,2 and Vadim Y. Arshavsky1,2 DOI:http://dx.doi.org/10.1523/ENEURO.0144-18.2018 1Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710 and 2Albert Eye Research Institute, Duke University, Durham, North Carolina 27710 Visual Overview The heterotrimeric G-protein transducin mediates visual signaling in vertebrate photoreceptor cells. Many aspects of the function of transducin were learned from knock-out mice lacking its individual subunits. Of particular interest is ␥ ␥ the knockout of its rod-specific -subunit (G 1). Two stud- ies using independently generated mice documented that this knockout results in a considerable Ͼ60-fold reduction in the light sensitivity of affected rods, but provided dif- ␣ ␣ ferent interpretations of how the remaining -subunit (G t)  ␥ mediates phototransduction without its cognate G 1 1- subunit partner. One study found that the light sensitivity ␣ reduction matched a corresponding reduction in G t con- tent in the light-sensing rod outer segments and proposed ␣  that G t activation is supported by remaining G 1 asso- ciating with other G␥ subunits naturally expressed in pho- toreceptors. In contrast, the second study reported the same light sensitivity loss but a much lower, only approx- ␣ imately sixfold, reduction of G t and proposed that the light responses of these rods do not require G␥ at all. To resolve this controversy and elucidate the mechanism ␥ driving visual signaling in G 1 knock-out rods, we analyzed both mouse lines side by side. -
GNAI3 Gene G Protein Subunit Alpha I3
GNAI3 gene G protein subunit alpha i3 Normal Function The GNAI3 gene provides instructions for making one component, the inhibitory alpha subunit, of a protein complex called a guanine nucleotide-binding protein (G protein). G proteins are composed of three protein subunits: alpha, beta, and gamma. Each of these subunits is produced from a different gene. Through a process called signal transduction, G proteins trigger a complex network of signaling pathways within cells. These pathways help transmit information from outside the cell to inside the cell. Specifically, G proteins made with the GNAI3 inhibitory alpha subunit reduce (inhibit) the activity of an enzyme called adenylyl cyclase, which is an important chemical messenger within cells. G protein signaling ultimately influences many cell activities, instructing the cell to grow, divide, or take on specialized functions. Studies suggest that G protein signaling involving the GNAI3 inhibitory alpha subunit contributes to the development of the first and second pharyngeal arches. These embryonic structures ultimately develop into the jawbones, facial muscles, middle ear bones, ear canals, outer ears, and related tissues. Health Conditions Related to Genetic Changes Auriculo-condylar syndrome At least two mutations in the GNAI3 gene have been found to cause auriculo-condylar syndrome, a disorder that primarily affects the development of the ears and lower jaw ( mandible). The identified mutations change single protein building blocks (amino acids) in the inhibitory alpha subunit. These mutations likely alter the structure of the inhibitory alpha subunit and impair G protein signaling. Abnormal signaling alters the formation of the lower jaw: instead of developing normally, the lower jaw becomes shaped more like the smaller upper jaw (maxilla). -
Constitutively Active Mutant of Rod A-Transducin in Autosomal Dominant
HUMAN MUTATION Mutation in Brief #970 (2007) Online MUTATION IN BRIEF p.Gln200Glu, a Putative Constitutively Active Mutant of Rod α-Transducin (GNAT1) in Autosomal Dominant Congenital Stationary Night Blindness Viktoria Szabo1,2†, Hans-Jürgen Kreienkamp1†, Thomas Rosenberg3, and Andreas Gal1* 1Institut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; 3Gordon Norrie Centre for Genetic Eye Diseases, The National Eye Clinic for the Visually Impaired, Hellerup, Denmark; 2Permanent address: Department of Ophthalmology, Semmelweis University, Budapest, Hungary *Correspondence to: A. Gal, Institut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany; Tel.: 49-40-42803-2120; Fax: 49-40-42803-5138; E-mail: [email protected] Grant sponsor: Recognition Award of the Alcon Research Institute (Fort Worth, TX, to A.G.) and the German Academic Exchange Service (to V.S.). †Viktoria Szabo and Hans-Jürgen Kreienkamp contributed equally to this work. Communicated by Mark H. Paalman Congenital stationary night blindness (CSNB) is a non-progressive Mendelian condition resulting from a functional defect in rod photoreceptors. A small number of unique missense mutations in the genes encoding various members of the rod phototransduction cascade, e.g. rhodopsin (RHO), cGMP phosphodiesterase β-subunit (PDE6B), and transducin α-subunit (GNAT1) have been reported to cause autosomal dominant (ad) CSNB. While the RHO and PDE6B mutations result in constitutively active proteins, the only known adCSNB-associa- ted GNAT1 change (p.Gly38Asp) produces an α-transducin that is unable to activate its downstream effector molecule in vitro. In a multigeneration Danish family with adCSNB, we identified a novel heterozygous C to G transversion (c.598C>G) in exon 6 of GNAT1 that should result in a p.Gln200Glu substitution in the evolutionarily highly conserved Switch 2 region of α-transducin, a domain that has an important role in binding and hydrolyzing GTP. -
Multi-Functionality of Proteins Involved in GPCR and G Protein Signaling: Making Sense of Structure–Function Continuum with In
Cellular and Molecular Life Sciences (2019) 76:4461–4492 https://doi.org/10.1007/s00018-019-03276-1 Cellular andMolecular Life Sciences REVIEW Multi‑functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder‑based proteoforms Alexander V. Fonin1 · April L. Darling2 · Irina M. Kuznetsova1 · Konstantin K. Turoverov1,3 · Vladimir N. Uversky2,4 Received: 5 August 2019 / Revised: 5 August 2019 / Accepted: 12 August 2019 / Published online: 19 August 2019 © Springer Nature Switzerland AG 2019 Abstract GPCR–G protein signaling system recognizes a multitude of extracellular ligands and triggers a variety of intracellular signal- ing cascades in response. In humans, this system includes more than 800 various GPCRs and a large set of heterotrimeric G proteins. Complexity of this system goes far beyond a multitude of pair-wise ligand–GPCR and GPCR–G protein interactions. In fact, one GPCR can recognize more than one extracellular signal and interact with more than one G protein. Furthermore, one ligand can activate more than one GPCR, and multiple GPCRs can couple to the same G protein. This defnes an intricate multifunctionality of this important signaling system. Here, we show that the multifunctionality of GPCR–G protein system represents an illustrative example of the protein structure–function continuum, where structures of the involved proteins represent a complex mosaic of diferently folded regions (foldons, non-foldons, unfoldons, semi-foldons, and inducible foldons). The functionality of resulting highly dynamic conformational ensembles is fne-tuned by various post-translational modifcations and alternative splicing, and such ensembles can undergo dramatic changes at interaction with their specifc partners. -
Every Detail Matters. That Is, How the Interaction Between Gα Proteins and Membrane Affects Their Function
membranes Review Every Detail Matters. That Is, How the Interaction between Gα Proteins and Membrane Affects Their Function Agnieszka Polit * , Paweł Mystek and Ewa Błasiak Department of Physical Biochemistry, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland; [email protected] (P.M.); [email protected] (E.B.) * Correspondence: [email protected]; Tel.: +48-12-6646156 Abstract: In highly organized multicellular organisms such as humans, the functions of an individ- ual cell are dependent on signal transduction through G protein-coupled receptors (GPCRs) and subsequently heterotrimeric G proteins. As most of the elements belonging to the signal transduction system are bound to lipid membranes, researchers are showing increasing interest in studying the accompanying protein–lipid interactions, which have been demonstrated to not only provide the environment but also regulate proper and efficient signal transduction. The mode of interaction between the cell membrane and G proteins is well known. Despite this, the recognition mechanisms at the molecular level and how the individual G protein-membrane attachment signals are interre- lated in the process of the complex control of membrane targeting of G proteins remain unelucidated. This review focuses on the mechanisms by which mammalian Gα subunits of G proteins interact with lipids and the factors responsible for the specificity of membrane association. We summarize recent data on how these signaling proteins are precisely targeted to a specific site in the membrane region by introducing well-defined modifications as well as through the presence of polybasic regions Citation: Polit, A.; Mystek, P.; within these proteins and interactions with other components of the heterocomplex. -
The Potential Druggability of Chemosensory G Protein-Coupled Receptors
International Journal of Molecular Sciences Review Beyond the Flavour: The Potential Druggability of Chemosensory G Protein-Coupled Receptors Antonella Di Pizio * , Maik Behrens and Dietmar Krautwurst Leibniz-Institute for Food Systems Biology at the Technical University of Munich, Freising, 85354, Germany; [email protected] (M.B.); [email protected] (D.K.) * Correspondence: [email protected]; Tel.: +49-8161-71-2904; Fax: +49-8161-71-2970 Received: 13 February 2019; Accepted: 12 March 2019; Published: 20 March 2019 Abstract: G protein-coupled receptors (GPCRs) belong to the largest class of drug targets. Approximately half of the members of the human GPCR superfamily are chemosensory receptors, including odorant receptors (ORs), trace amine-associated receptors (TAARs), bitter taste receptors (TAS2Rs), sweet and umami taste receptors (TAS1Rs). Interestingly, these chemosensory GPCRs (csGPCRs) are expressed in several tissues of the body where they are supposed to play a role in biological functions other than chemosensation. Despite their abundance and physiological/pathological relevance, the druggability of csGPCRs has been suggested but not fully characterized. Here, we aim to explore the potential of targeting csGPCRs to treat diseases by reviewing the current knowledge of csGPCRs expressed throughout the body and by analysing the chemical space and the drug-likeness of flavour molecules. Keywords: smell; taste; flavour molecules; drugs; chemosensory receptors; ecnomotopic expression 1. Introduction Thirty-five percent of approved drugs act by modulating G protein-coupled receptors (GPCRs) [1,2]. GPCRs, also named 7-transmembrane (7TM) receptors, based on their canonical structure, are the largest family of membrane receptors in the human genome.